ClinicalTrialsFinder

3-year Disease-free Survival Clinical Trials in Shanghai, Shanghai Municipality

1 recruitingShanghai, Shanghai Municipality, China

Showing 1–1 of 1 trials

Recruiting
Phase 4

Befotertinib Adjuvant Therapy in Stage IA2-IB NSCLC Patients

3-year Disease-free Survival
Fudan University592 enrolled1 locationNCT06561620